Senior Director/Vice President, Preclinical Pharmacology & Toxicology jobs in United States
info-icon
This job has closed.
company-logo

Salubris Biotherapeutics · 1 week ago

Senior Director/Vice President, Preclinical Pharmacology & Toxicology

Salubris Biotherapeutics is seeking a visionary and experienced leader to join our team as Senior Director or Vice President, Preclinical Pharmacology & Toxicology. This foundational leadership role offers the opportunity to further establish and lead the Preclinical Pharmacology, Pharmacometrics, and Toxicology function, driving research programs from lead optimization through IND submission.

BiotechnologyHealth CarePharmaceutical

Responsibilities

Serve as a key strategic leader, partnering with the CSO to shape preclinical development strategy across the portfolio
Drive the strategic vision for advancing programs from late-stage discovery through IND/CTA submission, ensuring alignment with corporate objectives and competitive positioning
Anticipate regulatory and scientific challenges, and proactively develop risk mitigation strategies to accelerate program timelines
Design, manage, and interpret pharmacology, PK/PD, and toxicology studies (GLP/non-GLP) to support program advancement
Oversee CRO partnerships, protocol development, study monitoring, and regulatory documentation to deliver high-quality nonclinical data packages
Lead cross-functional collaboration with Bioanalytical, CMC, and Clinical teams to develop integrated nonclinical safety, translational science and CMC development strategies
Ensure seamless translation of preclinical findings into clinical development plans
Mentor and develop internal team members, building organizational capabilities in disease- and target-relevant efficacy studies, PK/PD/biomarker strategies, and translational approaches across cardiovascular/metabolic and oncology therapeutic areas

Qualification

PhD in relevant field10+ years industry experienceLeadership in preclinical pharmacologyVivo pharmacology knowledgeBioanalysisDMPK knowledgeBiologicsCardiovascular/metabolic experienceOncology experienceSelf-motivated leaderStrategic thinkingCommunication skillsInterpersonal skillsCollaborative work

Required

PhD in Biology, Biochemistry, Biomedical Sciences, Pharmacology, Toxicology, Pharmaceutical Sciences, or related scientific discipline
10+ years of relevant pharmaceutical/biotechnology industry experience, including 5+ years in a leadership capacity within preclinical pharmacology, toxicology, and/or DMPK
Demonstrated ability as program lead to advance programs from lead optimization to IND with complex biologics, such as antibodies, and/or antibody conjugates (ADCs, AOCs)
Deep understanding of in vivo pharmacology and toxicology
Solid working knowledge in bioanalysis, PK/PD, and DMPK. Relevant experience with both biologics and small molecules is a strong plus
Experience delivering high-quality preclinical/nonclinical data packages for drug candidate selection and IND-enabling studies

Preferred

Experience with cardiovascular/metabolic therapeutic area or oncology preferred

Benefits

Competitive compensation package including base salary
Performance bonus
Equity participation
Comprehensive benefits

Company

Salubris Biotherapeutics

twittertwitter
company-logo
SalubrisBio was founded in August 2016 as a subsidiary of the China-based pharmaceutical company Salubris Pharmaceuticals Co. Ltd. (www.salubris.com).

Funding

Current Stage
Early Stage
Total Funding
$102M
Key Investors
Shenzhen Salubris Pharmaceuticals
2024-04-22Series A· $35M
2023-03-28Corporate Round· $35M
2022-03-07Corporate Round· $32M

Leadership Team

leader-logo
Samuel Murphy
Chief Executive Officer
linkedin
leader-logo
Jijun Dong
Chief Scientific Officer
linkedin
Company data provided by crunchbase